Similar articles for PMID: 9560343

Year	Number of Results
1994	1
1995	2
1996	3
1997	9
1998	7
1999	9
2000	6
2001	14
2002	6
2003	3
2004	8
2005	3
2006	1
2013	1
2024	0

1

Identification of a ligand for the death-domain-containing receptor Apo3.

Marsters SA, Sheridan JP, Pitti RM, Brush J, Goddard A, Ashkenazi A. Marsters SA, et al. Curr Biol. 1998 Apr 23;8(9):525-8. doi: 10.1016/s0960-9822(98)70204-0. Curr Biol. 1998. PMID: 9560343 Free article.

2

TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95).

Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schröter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR, Tschopp J. Bodmer JL, et al. Immunity. 1997 Jan;6(1):79-88. doi: 10.1016/s1074-7613(00)80244-7. Immunity. 1997. PMID: 9052839 Free article.

3

Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B.

Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Bauer KD, Ashkenazi A. Marsters SA, et al. Curr Biol. 1996 Dec 1;6(12):1669-76. doi: 10.1016/s0960-9822(02)70791-4. Curr Biol. 1996. PMID: 8994832 Free article.

4

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT. Walczak H, et al. EMBO J. 1997 Sep 1;16(17):5386-97. doi: 10.1093/emboj/16.17.5386. EMBO J. 1997. PMID: 9311998 Free PMC article.

5

Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.

Qin JZ, Bacon P, Chaturvedi V, Nickoloff BJ. Qin JZ, et al. J Invest Dermatol. 2001 Oct;117(4):898-907. doi: 10.1046/j.0022-202x.2001.01477.x. J Invest Dermatol. 2001. PMID: 11676830 Free article.

6

TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.

Kim YS, Schwabe RF, Qian T, Lemasters JJ, Brenner DA. Kim YS, et al. Hepatology. 2002 Dec;36(6):1498-508. doi: 10.1053/jhep.2002.36942. Hepatology. 2002. PMID: 12447876

7

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.

Secchiero P, Milani D, Gonelli A, Melloni E, Campioni D, Gibellini D, Capitani S, Zauli G. Secchiero P, et al. J Leukoc Biol. 2003 Aug;74(2):223-32. doi: 10.1189/jlb.0103004. J Leukoc Biol. 2003. PMID: 12885939

8

Apoptosis-mediating receptor-ligand systems in human retinal pigment epithelial cells.

Hueber A, Aduckathil S, Kociok N, Welsandt G, Dinslage S, Kirchhof B, Esser PJ. Hueber A, et al. Graefes Arch Clin Exp Ophthalmol. 2002 Jul;240(7):551-6. doi: 10.1007/s00417-002-0487-6. Epub 2002 Jun 20. Graefes Arch Clin Exp Ophthalmol. 2002. PMID: 12136286

9

IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC.

Ramaswamy M, Efimova EV, Martinez O, Mulherkar NU, Singh SP, Prabhakar BS. Ramaswamy M, et al. Oncogene. 2004 Aug 12;23(36):6083-94. doi: 10.1038/sj.onc.1207804. Oncogene. 2004. PMID: 15208670

10

The receptor for the cytotoxic ligand TRAIL.

Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM. Pan G, et al. Science. 1997 Apr 4;276(5309):111-3. doi: 10.1126/science.276.5309.111. Science. 1997. PMID: 9082980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

73 results

Results by year